首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1672808

主動式植入式醫療設備市場（按產品、最終用戶和地區分類）

Active Implantable Medical Devices Market, By Product, By End Users, By Geography

出版日期: 2025年02月13日 | 出版商:

Coherent Market Insights | 英文 197 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球主動植入式醫療設備市場規模預估為 274.1 億美元，預計到 2032 年將達到 452.1 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 7.4%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	274.1億美元
效能資料	2020-2024	預測期	2025-2032
預測期：2025 年至 2032 年複合年成長率	7.40％	2032 年金額預測	452.1億美元

數字。 2025 年各地區主動植入式醫療設備市場佔有率（%）

全球主動植入式醫療設備市場的成長受到全球人口老化加劇和慢性病發病率上升的推動。主動式植入式醫療設備是電池供電的醫療設備，植入人體內部以治療各種醫療狀況。主要的主動植入式醫療設備包括植入式心臟整流去顫器（ICD）、神經刺激設備、植入式藥物幫浦。 ICD 廣泛用於治療危及生命的心臟疾病，例如心搏過速和心室顫動。神經刺激設備有助於治療慢性疼痛以及癲癇和帕金森氏症等神經系統疾病。植入式藥物幫浦有助於有效局部輸送藥物，治療癌症和關節炎等疾病。持續的醫學發展和對開發小型化和技術先進的植入式設備的日益關注可能會在預測期內推動主動植入式醫療設備市場的成長。

市場動態

老齡人口日益增多，慢性病頻繁，微創手術需求不斷成長，心臟疾病和神經系統疾病發病率不斷上升，這些都可能推動全球有源植入式醫療設備市場的成長。根據聯合國統計，到2050年，全球60歲及以上人口預計將從目前的10億增加到21億。與傳統藥物療法和醫療設備相比，植入式醫療設備因其長期療效和易於遠端監控等優勢，越來越受到人們的偏好，這推動了有源植入式醫療設備的普及。然而，高成本植入式醫療設備的報銷範圍有限（尤其是在開發中國家）、由於安全問題而頻繁召回產品以及嚴格的監管核准可能會阻礙預測期內的市場發展。機器人、生物列印和 3D 列印領域的持續技術創新，以及用於長期植入的小型電池供電設備的開發，可以為有源植入式醫療設備市場參與企業提供成長機會。

研究的主要特點

本報告對全球主動植入式醫療設備市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。

它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球有源植入式醫療設備市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行的分析。

主要企業包括美敦力、科利耳有限公司、雅培、LivaNova PLC、波士頓科學公司和 Myomo, Inc.

本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

全球有源植入式醫療設備市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。

相關人員可以透過全球主動植入式醫療設備市場分析中使用的各種策略矩陣來促進決策。

公司簡介
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- LivaNova PLC
- BIoTronik SE &Co. KG
- Cochlear Ltd.
- William Demant Holding A/S
- Sonova Holding AG
- MED-EL
- Nurotron BIoTechnology Co. Ltd.
- Zimmer Biomet Holdings, Inc.
- Nevro Corp.
- Second Sight Medical Products, Inc.
- Nuvectra Corporation
- Aleva Neurotherapeutics SA
- Pixium Vision
- Retina Implant AG
- Corindus Vascular Robotics, Inc.

第 9 章分析師建議

興衰
一致的機會地圖

第10章調查方法

參考
調查方法

簡介目錄

Product Code: CMI1126

Global Active Implantable Medical Devices Market is estimated to be valued at USD 27.41 Bn in 2025 and is expected to reach USD 45.21 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 27.41 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.40%	2032 Value Projection:	USD 45.21 Bn

Figure. Active Implantable Medical Devices Market Share (%), By Region 2025

Active Implantable Medical Devices Market - IMG1

Global active implantable medical devices market growth is driven by rising aging population and increasing prevalence of chronic diseases worldwide. Active implantable medical devices are battery-powered medical devices that are implanted inside the human body to treat various medical conditions. Some key active implantable medical devices include implantable cardioverter defibrillators (ICDs), neurostimulators, and implantable drug pumps. ICDs are extensively used to treat life-threatening cardiac conditions like tachycardia and ventricular fibrillation. Neurostimulators help in managing chronic pain as well as neurological disorders such as epilepsy and Parkinson's disease. Implantable drug pumps assist in effective localized drug delivery for conditions like cancer and arthritis. Ongoing medical advancement and growing focus on development of miniaturized and technologically advanced implantable devices can drive the active implantable medical devices market growth during the forecast period.

Market Dynamics:

Rising geriatric population base that is highly susceptible to chronic diseases, increasing demand for minimally invasive procedures, growing prevalence of cardiac disorders and neurological conditions can drive the global active implantable medical devices market growth. According to the United Nations, the population aged 60 years and above is projected to reach 2.1 billion globally by 2050 from 1 billion currently. Growing preference for implantable devices over conventional drug therapy and medical devices due to advantages such as long-term effectiveness and easy remote monitoring can boost adoption of active implantable medical devices. However, limited reimbursement coverage for high-cost implantable devices especially in developing nations, frequent product recalls owing to safety issues, and stringent regulatory approvals can hamper the market growth during the forecast period. Ongoing technological innovation in the field of robotics, bioprinting, 3D printing and development of miniature battery powered devices for long term implantation can offer growth opportunities for active implantable medical devices market players.

Key features of the study:

This report provides in-depth analysis of the global active implantable medical devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global active implantable medical devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Medtronic, Cochlear Ltd, Abbott, LivaNova PLC, Boston Scientific Corporation, Myomo, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global active implantable medical devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global active implantable medical devices market

Detailed Segmentation-

By Product
- Implantable Cardioverter Defibrillators
- Implantable Cardiac Pacemakers
- Ventricular Assist Devices
- Implantable Heart Monitors/Insertable Loop Recorders
- Neurostimulators
- Implantable Hearing Devices
- Others
By End Users
- Hospitals
- Ambulatory Surgery Center
- Specialty Clinics
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- LivaNova PLC
- Biotronik SE & Co. KG
- Cochlear Ltd.
- William Demant Holding A/S
- Sonova Holding AG
- MED-EL
- Nurotron Biotechnology Co. Ltd.
- Zimmer Biomet Holdings, Inc.
- Nevro Corp.
- Second Sight Medical Products, Inc.
- Nuvectra Corporation
- Aleva Neurotherapeutics SA
- Pixium Vision
- Retina Implant AG
- Corindus Vascular Robotics, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By End User
- Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Active Implantable Medical Devices Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Active Implantable Medical Devices Market, By Product, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Implantable Cardioverter Defibrillators
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Implantable Cardiac Pacemakers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ventricular Assist Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Implantable Heart Monitors/Insertable Loop Recorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurostimulators
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Implantable Hearing Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (fully-automatic vial-filling machine, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Active Implantable Medical Devices Market, By End User, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory Surgery Center
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Active Implantable Medical Devices Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Medtronic plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Abbott Laboratories
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boston Scientific Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- LivaNova PLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Biotronik SE & Co. KG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cochlear Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- William Demant Holding A/S
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sonova Holding AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- MED-EL
- Nurotron Biotechnology Co. Ltd.
- Zimmer Biomet Holdings, Inc.
- Nevro Corp.
- Second Sight Medical Products, Inc.
- Nuvectra Corporation
- Aleva Neurotherapeutics SA
- Pixium Vision
- Retina Implant AG
- Corindus Vascular Robotics, Inc.